Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.440
-0.090 (-2.55%)
At close: Jun 27, 2025, 4:00 PM
3.450
+0.010 (0.29%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $294.39 million as of June 27, 2025. Its market cap has decreased by -7.77% in one year.
Market Cap
294.39M
Enterprise Value
-128.74M
1-Year Change
-7.77%
Ranking
Category
Stock Price
$3.44
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $294.39M, a decrease of -84.81%. That is a compound annual growth rate of -33.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 302.10M | 6.77% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.02B |
| Johnson & Johnson | 365.12B |
| AbbVie | 329.38B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.69B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.17B |
| AstraZeneca | 216.45B |